Brand comparisons in the 7-OH category are a specific kind of buyer work: not taste, not flavor, not price first — verification first, because in 2026 the difference between brands is the paperwork, and the paperwork is checkable. This post is the comparison method: the four criteria that decide a brand comparison, the order to run them in, and what each one looks like when a brand passes or fails. The companion reads are the evaluation framework (the brand-level version) and the 9-point checklist (the purchase-level version); this post is the comparison between two or more brands you are actually choosing between. Standing rules: 21+ adult product, no medical claims, and the state map check before any of it.
The four criteria, in decision order
- Batch-COA program (the dealbreaker). Does the brand publish a third-party lab report per batch, matchable to the printed batch number? Not per brand, not per product line — per batch, current, with the 7-hydroxymitragynine content and the related-compound screens. In 2026, with the scheduled analogs (the DEA update has the actions), the related-compound screens are part of the standard, not an extra. A brand that fails this criterion is out of the comparison before the pricing is looked at — the batch verification post is the five-minute check a buyer runs to confirm it.
- Honest strength labeling. Is the printed milligram the amount of 7-hydroxymitragynine per unit — verifiable against the COA — or a blend amount that makes the number uncomputable? The what is 7-OH post covers the labeling basics, and the strength post covers why the 100mg verifiable unit is the category’s standard ceiling. Two brands with the same printed milligram but different labeling honesty are not the same product.
- 21+ enforcement, actually enforced. Stated at checkout, enforced at delivery, published as policy — the age verification post describes the two-gate standard. A brand that states 21+ but ships without a signature gate has stated a policy it does not run, and the statement is the flag.
- Legal transparency. A published position on the state map and the federal moves: restricted-state exclusions in the shipping policy, a current federal status posture, no marketing that winks at the gray area. The 2026 environment — seven restricted states, the pending threshold rule — makes this criterion the one that separates a brand that will still be operating next year from one that is racing the regulators.
The second-tier criteria (tie-breakers, only after the first four)
- Per-100mg pricing at your price. The pricing guide is the method: normalize to per-100mg at the pack price you will actually order, add the vendor’s minimum and shipping structure, compare landed numbers. Reference point: our lines run Black Edition $29.99 regular / $24.99 current per 50mg unit and Platinum $44.99 regular / $34.99 current per 100mg unit, with the $120 minimum and the $500 free-shipping line — the bulk buying post has the worked orders. Price is a tie-breaker, never the decider, because a cheaper unverified milligram is the category’s classic error.
- Format honesty. Tablets and chewables are precision formats; a brand mixing gummies or powders under the same 7-OH banner should say so per product, with per-format COAs. The tablets vs gummies and tablets vs powder posts are the format comparisons.
- Responsible-use posture. A brand that publishes spacing rules, break guidance, and no-mixing rules — the responsible use standard — is signaling how it expects the product to be used. Absence of use guidance is a quiet outsourcing of that decision.
- Support quality. Can you reach a human about a batch, a COA, or an order? Our bar: Mon–Fri, 9am–5pm PT, a real phone number and inbox on the contact page. In a verified-milligram category, the support channel is part of the verification story.
How to actually run the comparison (the worksheet)
Two brands, four rows, one table — the whole method in five minutes:
| Criterion | Brand A | Brand B | Pass standard |
|---|---|---|---|
| Batch COAs | published per batch? screens clean? | same | Published, current, matchable |
| Strength labeling | mg of alkaloid per unit? | same | Specific, COA-verified |
| 21+ enforcement | two gates? published? | same | Checkout + signature, stated |
| Legal transparency | restricted states? federal posture? | same | Published, current, no winks |
The decision rule: a brand that fails any of the four rows is out; the tie-breakers decide between the survivors. If both brands pass all four rows, the per-100mg landed price is the first tie-breaker, format and support the rest. If neither passes all four rows, the correct purchase is no purchase — the legal alternatives post is the honest version of what to do instead.
How we score ourselves in the comparison (because you will ask)
Applying the table to Limitless 7OH: published per-batch COAs with the related-compound screens, 50mg/100mg units with specific alkaloid labeling, the two-gate 21+ system (checkout verification plus signature delivery, per the age verification post), and a published legal-and-shipping position that respects the restricted-state map. The about page covers the testing process in depth. We are one brand in the comparison, and the table is written to work on any of them — including us, if the paperwork ever lapses. That is the point of a method: it keeps the buyer the judge, the brand the defendant, and the paperwork the evidence.
Bottom line
Compare brands on the four rows — batch COAs, honest labeling, 21+ enforcement, legal transparency — in that order, and let the per-100mg landed price break the tie between the survivors. The evaluation framework is the single-brand version, the 9-point checklist is the purchase version, and the FAQ center carries the standing questions. The shop is where our verified units live — 21+ only, legal addresses only, batch COA on every pack.